AFM
ABEV icon

Armstrong Fleming & Moore’s Ambev ABEV Stock Holding History

Armstrong Fleming & Moore’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,766
Closed -$125K – 107
2025
Q1 		$125K Buy
+53,766
New +$108K 0.15% 78

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armstrong Fleming & Moore's ABEV Position: Q2 2025 in Review

Armstrong Fleming & Moore sold out of Ambev (ABEV) in Q2 2025, closing a stake of 53,766 shares — an estimated $125K sold.

Armstrong Fleming & Moore first reported a position in ABEV in Q1 2025 and held it in 1 quarter. The position peaked at $125K in Q1 2025. 356 funds tracked by Wall St. Rank hold ABEV as of Q2 2025.

  • Armstrong Fleming & Moore reported no remaining Ambev position as of Q2 2025 after selling out during the quarter.
  • Armstrong Fleming & Moore sold 53,766 Ambev shares in Q2 2025, an estimated $125K.
  • Armstrong Fleming & Moore first reported a position in Ambev in Q1 2025 and held it in 1 quarter.
  • Armstrong Fleming & Moore's Ambev position peaked at $125K in Q1 2025.
  • 356 funds tracked by Wall St. Rank held Ambev as of Q2 2025.

Based on Armstrong Fleming & Moore's 13F filing for Q2 2025, filed 23 Jul 2025.